Other differentially expressed genes include prospective therapeutic targets to treat diabetes such as MAP3K15 (40), as well as genes known to be associated with certain increased genetic risks for diabetes in humans (e.g., Pcsk2 and Pclo) (41, 42). This evidence concerns the gene PCSK2 and diabetes mellitus.